Computed tomography features and predictive findings of ruptured gastrointestinal stromal tumours
To evaluate the CT features of ruptured GISTs and factors that might be predictive of rupture through comparison with CTs taken prior to rupture and CTs of non-ruptured GIST.
Forty-nine patients with ruptured GIST and forty-nine patients with non-ruptured GIST matched by age, gender and location were included. Clinical data including pharmacotherapy were reviewed. The imaging features were analyzed. Prior CT obtained before rupture were evaluated.
The most common location of ruptured GIST was small bowel with mean size of 12.1 cm. Ruptured GIST commonly showed wall defects, >40 % eccentric necrosis, lobulated shaped, air density in mass, pneumoperitoneum, peritonitis, hemoperitoneum and ascites (p < 0.001–0.030). Twenty-seven of 30 patients with follow up imaging received targeted therapy. During follow-up, thickness of the tumour wall decreased. Increase in size and progression of necrosis were common during targeted therapy (p = 0.017).
Newly developed ascites, peritonitis and hemoperitoneum was more common (p < 0.001–0.036).
Ruptured GISTs commonly demonstrate large size, >40 % eccentric necrosis, wall defects and lobulated shape. The progression of necrosis with increase in size and decreased wall thickness during targeted therapy may increase the risk of rupture. Rupture should be considered when newly developed peritonitis, hemoperitoneum, or ascites are noted during the follow-up.
• Ruptured GISTs demonstrate large size, eccentric necrosis, wall defects, and lobulated shape.
• Rupture should be considered when peritonitis or hemoperitoneum/adjacent hematoma newly appears.
• Progression of necrosis with increase in size increases the risk of rupture.
KeywordsGastrointestinal stromal tumours Rupture Computed tomography Diagnostic imaging Intestinal neoplasm
The scientific guarantor of this publication is Hyun Jin Kim. The authors of this manuscript declare norelationships with any companies, whose products or services may be related to the subject matter ofthe article. The authors state that this work has not received any funding. No complex statisticalmethods were necessary for this paper. Institutional Review Board approval was obtained. Writteninformed consent was waived by the Institutional Review Board. Methodology: retrospective,diagnostic or prognostic study, performed at one institution.
- 11.Zhou C, Duan X, Zhang X, Hu H, Wang D, Shen J (2015) Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour. Eur Radiol 1–8Google Scholar
- 19.Kim R, Emi M, Arihiro K, Tanabe K, Uchida Y, Toge T (2005) Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer 103:1800–1809CrossRefPubMedGoogle Scholar
- 25.(2014) Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25 Suppl 3:iii21–26Google Scholar